Pandion Therapeutics' Series A Round

Pandion Therapeutics raised a round of funding on January 18, 2018.

Pandion Therapeutics has developed a proprietary therapeutic platform based on bispecific antibodies with targeting fragments that bind to specific tissues at the local site of inflammatory disease, c…

Articles about Pandion Therapeutics' Series A Round: